Keloid
Keloids are a type of abnormal scar tissue that results from an overgrowth of fibrous tissue following skin injury. Unlike typical scars which flatten over time, keloids extend beyond the original wound boundaries, presenting as raised, often firm, rubbery, or shiny growths on the skin. They can vary in color from pink to red or dark brown and are commonly found on the chest, shoulders, earlobes, and face, though they can occur anywhere on the body where skin has been damaged. Injuries such as cuts, burns, surgical incisions, vaccinations, insect bites, and even acne or body piercings can trigger keloid formation.
Biological Basis
The formation of keloids is characterized by a dysregulated wound healing process, involving an excessive deposition of collagen and other extracellular matrix components by dermal fibroblasts. This uncontrolled proliferation and synthesis lead to the distinctive raised and spreading nature of keloids. Genetic factors play a significant role in an individual's susceptibility to keloid development. Genome-Wide Association Studies (GWAS) have identified specific susceptibility loci associated with keloids and hypertrophic scarring. For instance, research has pinpointed genetic variants in populations of European descent that increase the risk of keloid formation. [1] Similarly, large-scale GWAS in Japanese populations have identified several novel susceptibility loci. [2] One such finding highlights a variant, rs192314256 (p.E62G of PHLDA3), which shows a substantial effect size for keloid risk in Japanese individuals. [2] This variant is predicted to have a deleterious effect on protein function, and it is hypothesized that a damaged PHLDA3 may activate the AKT signaling pathway, thereby promoting increased collagen production from dermal fibroblasts and contributing to keloid development. [2] The identification of population-specific genetic architectures, such as those found in East Asian populations, underscores the diverse genetic underpinnings of keloid susceptibility. [2]
Clinical Relevance
Clinically, keloids can cause a range of symptoms beyond their cosmetic appearance, including itching, pain, tenderness, and a burning sensation. Depending on their location and size, they can also restrict movement, particularly when they form over joints. Management of keloids is challenging, as they often recur even after surgical removal. Current treatment options include corticosteroid injections, cryotherapy, laser therapy, radiation, and pressure dressings, often used in combination. Understanding the genetic basis of keloids is crucial for developing more targeted and effective preventative strategies and therapies.
Social Importance
Keloids carry significant social and psychological importance due to their visible nature and potential for discomfort. Their impact on self-esteem, body image, and quality of life can be substantial, leading to psychological distress and social avoidance. The disproportionate prevalence of keloids in certain ethnic groups, particularly those with darker skin tones, also highlights the importance of culturally sensitive approaches to diagnosis, treatment, and support. Genetic research into keloids, by identifying specific risk factors, holds the promise of personalized medicine approaches, potentially leading to earlier intervention or preventative measures for individuals at high risk, thereby mitigating both the physical and social burdens of this condition.
Methodological and Statistical Constraints
The presented GWAS findings, while significant, are subject to several methodological and statistical constraints that influence their interpretation and generalizability. Notably, the absolute quantification of heritability estimates derived from generalized linear mixed models (GLMM) can be biased, as the effective sample size may diverge from the true sample size, potentially affecting the reliability of heritability estimations. [2] Furthermore, the inherent complexity of linkage disequilibrium (LD) poses a significant hurdle in pinpointing precise causal variants within identified genomic regions, even when studies employ strategies to narrow down potential candidates. [2]
A critical limitation for novel findings is the insufficient statistical power for comprehensive replication analyses, particularly when validating new signals across diverse populations. [2] Replication failures, especially for variants with lower minor allele frequencies (MAF), can arise from inadequate statistical power rather than true absence of association. [2] The inclusion of a large number of rare variants (MAF < 1%) in analyses, while increasing coverage, also raises the potential for increased type-I errors if standard genome-wide significance thresholds are not rigorously adjusted for the expanded testing burden. [2]
Ancestry and Generalizability
The generalizability of genetic susceptibility loci for keloids is limited by the specific ancestral populations studied. One major meta-analysis focused exclusively on European cohorts, while another large-scale GWAS was conducted in a Japanese population, representing East Asian ancestry. [1] Significant trans-ethnic differences in minor allele frequencies (MAF) have been observed for both novel and known disease-associated variants, with these differences being more pronounced for novel variants. [2] This suggests that genetic findings may not be directly transferable across populations, as the allele frequencies and effect sizes can vary substantially due to differing demographic histories and selective pressures. [2]
Moreover, observed heterogeneity in effect size estimates between populations can be attributed to distinct LD structures, where a variant might tag a causal allele only in specific ancestral groups, or because the true effect sizes genuinely differ. [2] This highlights the importance of performing GWAS in non-European populations to uncover population-specific genetic architectures and ensure equitable understanding of disease susceptibility across global populations. [2] Without broader representation, the full spectrum of genetic risk factors for keloids remains incompletely characterized.
Unaccounted Factors and Etiological Complexity
While GWAS effectively identifies genetic susceptibility loci, the comprehensive etiology of keloids involves factors beyond the genetic variants typically detected. The studies, by nature, focus on common genetic variants and, even with the inclusion of rare variants, may not fully capture the contribution of all genetic architectures, such as structural variations or epigenetic modifications, to keloid heritability. Although some studies adjust for known confounders like age, sex, and population substructure using principal components [3] the intricate interplay of environmental or gene-environment (GxE) factors is challenging to fully account for within a GWAS framework.
The influence of specific environmental triggers (e.g., trauma, inflammation, infection) and their interactions with genetic predispositions remain areas requiring further elucidation. Such unmeasured or unmodeled confounders could modulate genetic effects, leading to an incomplete understanding of individual keloid risk and progression. Therefore, despite identifying significant genetic associations, a substantial portion of keloid heritability and the complete causal pathways may still be influenced by factors not fully captured or resolved by current large-scale genetic association studies.
Variants
Genetic variations play a crucial role in an individual's susceptibility to keloid formation, a complex fibroproliferative disorder characterized by excessive scar tissue growth. Numerous single nucleotide polymorphisms (SNPs) across various genes have been identified as potential contributors to this condition, influencing diverse cellular pathways involved in wound healing, inflammation, and extracellular matrix remodeling. These variants often exert their effects by altering gene expression, protein function, or cellular signaling, leading to the uncontrolled fibroblast proliferation and collagen overproduction characteristic of keloids.
One significant susceptibility locus identified in the Japanese population is the PHLDA3 gene, particularly the missense variant rs192314256 (p.E62G). PHLDA3 (Pleckstrin Homology Like Domain Family A Member 3) is known to function as a tumor suppressor gene, playing a role in cell cycle regulation and apoptosis. The p.E62G variant is predicted to have a deleterious effect on its protein function, suggesting that a compromised PHLDA3 protein may contribute to keloid development. [2] Research indicates that a damaged PHLDA3 might activate the AKT signaling pathway, which is strongly associated with increased collagen production by dermal fibroblasts, thereby promoting the excessive scarring seen in keloids. [2] This variant shows a substantial effect size for keloid risk, making it a key genetic marker for the condition in East Asian populations. [2]
Other variants across several genes are also implicated in keloid predisposition, affecting processes from cell adhesion to immune response. The ITGA11 gene, encoding Integrin Alpha 11, is crucial for cell adhesion and interaction with the extracellular matrix, particularly collagen, and its variant rs34647667 may influence these interactions, contributing to altered tissue remodeling in keloids. [1] Similarly, variants like rs549023067 in the FRMD4A and FRMD4A-AS1 locus, which are involved in cell polarity and signaling, could impact fibroblast behavior and migration, thereby affecting scar formation. [4] The NEDD4 gene (Neural Precursor Cell Expressed, Developmentally Down-Regulated 4), an E3 ubiquitin ligase, regulates the degradation of various proteins, including growth factor receptors, and its variants such as rs16976600, rs11632096, and rs8032158 might alter these regulatory mechanisms, potentially leading to aberrant signaling pathways that drive fibrosis. [1]
Additional genetic loci contribute to the complex etiology of keloids by influencing diverse cellular functions. Variants within the QRSL1P2 region, including rs10863683, rs11293015, and rs2378519, are associated with keloid risk, potentially affecting tRNA metabolism or gene regulation given that QRSL1P2 is a pseudogene. [4] The SLC22A18AS gene, an antisense RNA, and LINC02871 - RPS11P1, a long intergenic non-coding RNA and ribosomal protein pseudogene, with variants like rs76024540 and rs140716753 respectively, may exert regulatory roles over gene expression that impact wound healing pathways. [4] Furthermore, variants in genes like CSF2RB (rs536701773), involved in immune signaling, and TAFA2 (rs527569697), a chemokine-like protein, highlight the inflammatory component of keloid formation, while BPESC1 and MRPS22 (rs646315) are linked to basic cellular processes, demonstrating the broad genetic landscape underlying keloid susceptibility. [1]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs10863683 rs11293015 rs2378519 |
LINC01705 - QRSL1P2 | keloid |
| rs34647667 | ITGA11 - CORO2B | keloid |
| rs192314256 rs35383942 |
PHLDA3 | keloid |
| rs549023067 | FRMD4A, FRMD4A-AS1 | keloid |
| rs16976600 rs11632096 rs8032158 |
NEDD4 | keloid |
| rs76024540 | SLC22A18AS | keloid |
| rs536701773 | CSF2RB | keloid |
| rs527569697 | TAFA2 | keloid |
| rs646315 | BPESC1, MRPS22 | keloid |
| rs140716753 | LINC02871 - RPS11P1 | keloid |
Defining Keloid and Related Scarring
Keloids represent a distinct form of pathological scarring characterized by an excessive proliferation of fibrous tissue that extends beyond the original boundaries of the wound. [1] This outward growth differentiates keloids from hypertrophic scars, which, while also involving excessive collagen deposition, typically remain confined to the original site of injury. [1] The primary terminology used is "keloid," often discussed in conjunction with "hypertrophic scarring" due to their shared etiology in abnormal wound healing and similar clinical presentation in early stages, though their long-term behavior and treatment responses differ. Both conditions represent a significant clinical challenge due to their potential for disfigurement, functional impairment, and symptoms such as pruritus and pain.
Clinical and Nosological Classification
Within established medical nosology, keloids are categorized as a benign dermal fibroproliferative disorder arising from aberrant wound repair. For research purposes, particularly in large-scale genetic studies, clinical diagnoses of keloids are often established using standardized "PheCode criteria". [3] These criteria are rigorously applied, sometimes requiring confirmation on "at least three distinct occasions," to ensure accurate case ascertainment and a precise operational definition for study inclusion. [3] This categorical approach to diagnosis is crucial for distinguishing affected individuals (case groups) from healthy controls, thereby facilitating robust genetic association analyses.
Genetic Predisposition and Research Criteria
The conceptual framework for understanding keloids increasingly incorporates a significant genetic component, with research focusing on identifying "susceptibility loci" that predispose individuals to the condition. [1] This approach highlights keloids as a complex trait influenced by genetic factors, moving beyond purely environmental or injury-related triggers. In Genome-Wide Association Studies (GWAS), the "case group" is meticulously defined by individuals diagnosed with keloids according to "PheCode classification," while the "control group" consists of individuals explicitly documented as not having PheCode-defined diseases. [3] This systematic application of diagnostic and measurement criteria is essential for uncovering novel genetic associations and advancing the understanding of keloid pathogenesis.
Causes
Keloid formation is a complex process influenced primarily by an individual's genetic makeup, with various susceptibility loci identified across different populations. The development of keloids is understood to be polygenic, meaning multiple genes contribute to an individual's risk, rather than being determined by a single genetic variant. Research efforts, particularly through genome-wide association studies (GWAS), continue to uncover specific genetic factors and their underlying molecular mechanisms.
Genetic Predisposition and Polygenic Inheritance
Keloids are strongly influenced by genetic factors, with numerous inherited variants contributing to an individual's susceptibility. Genome-wide association studies (GWAS) have identified several susceptibility loci for keloids and hypertrophic scarring, indicating a polygenic risk architecture in affected individuals. [1] This polygenic inheritance means that multiple genes, each with a small effect, collectively increase the likelihood of developing keloids. Initial studies in Japanese populations successfully identified four such susceptibility loci, establishing a clear genetic basis for the condition. [4] Subsequent, larger-scale GWAS in European populations have further expanded the understanding of the polygenic nature of keloid risk, revealing additional genetic regions associated with the trait. [1]
Specific Susceptibility Loci and Molecular Pathways
Specific genetic variants have been linked to keloid development, shedding light on potential molecular mechanisms. For instance, a large-scale GWAS in a Japanese population identified a novel susceptibility locus involving a missense variant, p.E62G, in the PHLDA3 gene. [2] This variant is predicted to have a deleterious effect on the PHLDA3 protein's function and is associated with a significantly increased risk for keloid, demonstrating a substantial effect size. Damaged PHLDA3 is hypothesized to activate the AKT signaling pathway, which is known to increase collagen production from dermal fibroblasts, thereby promoting keloid development. [2] These findings highlight how specific genetic alterations can disrupt cellular pathways crucial for normal wound healing, leading to excessive scar tissue formation.
Population Diversity and Genetic Discovery
The genetic architecture of keloid susceptibility can vary significantly across different populations, underscoring the importance of diverse genetic studies. Studies in European populations have identified several susceptibility loci, while research in Japanese populations has uncovered distinct and novel genetic variants, such as the PHLDA3 p.E62G variant, which might be difficult to discover in European populations due to restrictive allele frequencies. [1] These differences in genetic findings across ethnic groups are often attributed to variations in allele frequencies and linkage disequilibrium (LD) structures, which can influence the ability of GWAS to detect causal variants. Therefore, conducting genetic studies in diverse populations is crucial for a comprehensive understanding of keloid etiology, as it allows for the identification of population-specific genetic risk factors and their roles in disease manifestation. [2]
Genetic Predisposition and Population Specificity
Keloid formation is significantly influenced by an individual's genetic makeup, with genome-wide association studies (GWAS) revealing specific regions of the genome linked to susceptibility. Research conducted in the Japanese population has successfully identified novel genetic loci that contribute to keloid risk, some of which might be challenging to discover in European populations due to distinct allele frequencies. [2] For example, one study in a Japanese cohort identified four such susceptibility loci. [4] Concurrently, a GWAS meta-analysis focused on European populations has also pinpointed susceptibility loci associated with both keloids and hypertrophic scarring. [1] These findings underscore the complex genetic architecture of keloids and highlight the importance of studying diverse ethnic groups to fully characterize the genetic underpinnings of this condition.
Molecular Pathways and Cellular Dysregulation
The development of keloids is fundamentally driven by aberrant molecular signaling pathways and dysfunctional cellular processes, particularly within dermal fibroblasts. A critical pathway implicated in keloid pathology is the AKT signaling pathway, which is known to stimulate increased collagen production. [2] In keloids, the hyperactivation of this pathway leads to an excessive accumulation of collagen, a primary component of the extracellular matrix, resulting in the characteristic fibrotic scarring. This molecular imbalance represents a profound disruption in the normal homeostatic mechanisms that regulate tissue repair and remodeling.
The protein PHLDA3 plays a regulatory role in this context; a missense variant, p.E62G, in PHLDA3 is predicted to impair its protein function. [2] This functional impairment is hypothesized to result in the activation of the AKT pathway, thereby promoting the overproduction of collagen by dermal fibroblasts and contributing directly to keloid development. [2] Thus, the intricate interplay between PHLDA3 and the AKT pathway forms a central axis in the molecular pathogenesis of keloids.
Key Biomolecules and Their Roles
Several key biomolecules are integral to the abnormal processes underlying keloid formation, serving as critical mediators within the affected signaling pathways. One such molecule is the protein PHLDA3, which, when affected by the p.E62G missense variant (rs192314256), is predicted to suffer a deleterious impact on its protein function. [2] This particular variant has been associated with a significant effect size for keloid risk, suggesting its crucial role in predisposition. The compromised function of PHLDA3 is believed to lead to the activation of the AKT signaling pathway. [2]
The AKT pathway itself comprises a series of enzymes and regulatory proteins that, upon activation, modulate cellular growth, survival, and, importantly in keloids, the synthesis of collagen. The resultant surge in collagen production by dermal fibroblasts represents a major structural alteration in the skin. Therefore, both PHLDA3 and the various components of the AKT pathway are critical biomolecules whose dysregulation directly contributes to the characteristic excessive tissue remodeling seen in keloids.
Pathophysiology of Keloid Formation
Keloids represent a severe deviation from normal wound healing, characterized by an uncontrolled and progressive growth of scar tissue that extends beyond the original boundaries of the injury. This pathophysiological process involves an exacerbated proliferation of dermal fibroblasts and a pronounced overproduction and deposition of extracellular matrix components, predominantly collagen. [2] The sustained activation of molecular pathways, such as the AKT signaling pathway, potentially driven by functional deficits in proteins like PHLDA3, perpetuates this cycle of excessive tissue formation and fibrotic scarring. [2]
At the tissue and organ level, keloids manifest as raised, firm, and often hyperpigmented lesions that continue to expand over time. This uncontrolled growth is a direct consequence of the profound disruption in the delicate balance between collagen synthesis and degradation, leading to a net accumulation of fibrous tissue. The persistent nature and progressive enlargement of keloids underscore a fundamental failure in the body's ability to restore skin homeostasis following injury, resulting in a chronic state of tissue dysregulation.
Signaling Pathway Dysregulation in Keloid Formation
Keloid formation is closely linked to dysregulated cellular signaling pathways that drive excessive extracellular matrix production. A key pathway implicated in this process is the AKT signaling pathway, which is known to promote increased collagen synthesis in dermal fibroblasts. In keloid pathology, a compromised or damaged PHLDA3 protein may lead to the aberrant activation of the AKT pathway. This activation subsequently stimulates fibroblasts to overproduce collagen, a hallmark feature contributing to the characteristic hypertrophic scarring and tissue expansion seen in keloids. [2] The persistent activation of these intracellular signaling cascades, potentially through disrupted feedback loops involving PHLDA3, creates an environment conducive to fibrotic overgrowth.
Genetic and Post-Translational Regulatory Mechanisms
Genetic variations play a crucial role in predisposing individuals to keloids by affecting protein function and subsequent regulatory mechanisms. A specific missense variant, p.E62G, within the PHLDA3 gene, corresponding to *rs192314256*, is predicted to have a deleterious impact on the PHLDA3 protein's normal function. [2] This alteration represents a form of post-translational dysregulation, where the modified protein may fail to exert its inhibitory or regulatory effects on downstream pathways, such as the AKT pathway. Such genetic predispositions can disrupt the intricate gene regulation networks, leading to a cascade of events that promote fibroblast proliferation and collagen deposition, thereby driving keloid development.
Extracellular Matrix Remodeling and Cellular Biosynthesis
A central mechanism in keloid pathology involves the profound dysregulation of extracellular matrix (ECM) remodeling, primarily characterized by an excessive accumulation of collagen. The increased collagen production from dermal fibroblasts, as a consequence of activated signaling pathways like AKT, reflects an altered state of cellular biosynthesis. [2] This heightened biosynthetic activity requires substantial energy metabolism and the efficient flux of precursor molecules for collagen assembly. The imbalance between collagen synthesis and degradation pathways leads to the characteristic fibrous overgrowth, indicating a fundamental shift in metabolic regulation within keloid fibroblasts towards anabolic processes for ECM components.
Population-Specific Genetic Architecture and Pathway Implications
The genetic architecture underlying keloid susceptibility can vary significantly across different populations, influencing the identification and understanding of disease-relevant mechanisms. For instance, specific novel susceptibility loci, such as the p.E62G variant in PHLDA3 (*rs192314256*), have been identified with a large effect size in Japanese populations. [2] These variants might be challenging to discover in European populations due to differing allele frequencies and linkage disequilibrium structures. [2] This highlights a systems-level integration where population-specific genetic backgrounds can influence the prevalence and penetrance of pathway dysregulation, underscoring the need for diverse genetic studies to fully map the complex network interactions contributing to keloid pathogenesis.
Epidemiological Insights and Ancestry-Specific Associations
Population studies reveal significant variations in keloid susceptibility across different ancestral groups, highlighting the role of genetic factors in its etiology. Genome-wide association studies (GWAS) have been instrumental in identifying population-specific susceptibility loci. For instance, a meta-analysis focused on European populations identified specific genetic loci associated with both keloids and hypertrophic scarring. [1] In contrast, studies conducted within East Asian populations have uncovered distinct genetic architectures, with a GWAS in the Japanese population pinpointing four specific susceptibility loci for keloid. [4]
Further large-scale investigations in Japanese cohorts, involving 812 keloid cases and over 211,000 controls, identified novel susceptibility loci, including a significant association at the PHLDA3 region. [2] These cross-population comparisons underscore that the genetic underpinnings of keloid formation can vary considerably between ethnic groups, suggesting that different populations may benefit from ancestry-specific genetic screening and risk assessment strategies. The observed differences in genetic associations across European and East Asian populations emphasize the importance of diverse population cohorts in understanding the full spectrum of keloid genetics.
Large-Scale Cohort Studies and Longitudinal Data
Major population cohorts and biobank studies provide invaluable resources for understanding the genetic architecture and temporal patterns of keloid and other diseases. The BioBank Japan (BBJ), for example, has been utilized in large-scale GWAS efforts, contributing to the identification of novel susceptibility loci for various diseases, including keloid, within the Japanese population. [2] These extensive cohorts enable the analysis of disease prevalence and incidence rates across a broad demographic spectrum.
Similarly, the HiGenome cohort in Taiwan, comprising 323,397 participants of Taiwanese Han ancestry, offers rich longitudinal data derived from electronic medical records (EMRs) spanning up to 19 years. [3] This deep integration of physician-documented EMRs allows for robust investigations into the natural history of diseases and their temporal patterns, revealing that the incidence of many conditions, including those potentially related to scarring, increases with age. [3] Such longitudinal datasets are critical for capturing the dynamic aspects of disease development and for evaluating the long-term impacts of genetic predispositions within specific East Asian populations.
Methodological Approaches in Population Genetics
Population studies on keloid employ rigorous methodologies to ensure the reliability and generalizability of their findings. Large-scale GWAS, such as those conducted in Japanese and Taiwanese populations, typically involve substantial sample sizes, with tens to hundreds of thousands of participants, enabling the detection of genetic variants with small effect sizes. [2] Study designs often involve case-control comparisons, where disease diagnoses are meticulously established using standardized criteria like PheCodes applied on multiple occasions, enhancing the accuracy of phenotypic classification. [3]
Genetic data acquisition involves genotyping using high-density SNP arrays and subsequent stringent quality control (QC) steps, including filtering for call rates, Hardy-Weinberg equilibrium, minor allele frequency, and performing principal component analysis (PCA) to correct for population stratification and ensure ancestry homogeneity. [2] Imputation techniques, often utilizing reference panels like the 1000 Genomes Project, are applied to infer missing genotypes, thereby increasing the coverage of genetic variants. [2] Statistical analyses typically involve sophisticated models like generalized linear mixed models or logistic regression, adjusted for potential confounders such as age, sex, and principal components, to identify significant genetic associations while accounting for sample relatedness and other biases. [2]
Frequently Asked Questions About Keloid
These questions address the most important and specific aspects of keloid based on current genetic research.
1. Why do I get keloids when my family doesn't?
Keloid formation is strongly influenced by your individual genetic makeup. Even if your immediate family doesn't show keloids, you might have inherited specific genetic variants that make your wound healing process prone to excessive collagen production, leading to keloid development. This highlights the complex and sometimes unique genetic susceptibility in individuals.
2. Does my Asian background mean I'm more likely to get keloids?
Yes, studies have shown that keloid susceptibility varies across ethnic groups. For instance, large-scale genetic studies in Japanese populations have identified specific genetic variants, like one in the PHLDA3 gene, that significantly increase keloid risk in East Asian individuals. This suggests your ancestry can indeed play a role in your predisposition.
3. If I get a new piercing, will I definitely get a keloid?
Not necessarily, but if you have a genetic predisposition, any skin injury like a piercing significantly increases your risk. Keloids are triggered by damage to the skin, and if your body's wound healing process is genetically wired for overgrowth, that injury can lead to a keloid. It's the combination of genetic susceptibility and a skin wound.
4. Why do my keloids always come back after treatment?
Keloids are notoriously challenging to treat because the underlying genetic predisposition to dysregulated wound healing remains. Even after removal or treatment, your body's cells, specifically dermal fibroblasts, are genetically programmed to produce excessive collagen, leading to a high chance of recurrence at the site of new injury from treatment.
5. Why do my friends scar normally, but I get keloids?
It comes down to your unique genetics. Your body's wound healing response is different from your friends' due to specific inherited genetic factors. These factors cause your fibroblasts to overproduce collagen and extracellular matrix components, leading to the characteristic raised and spreading keloids, unlike typical flat scars.
6. Will my kids inherit my tendency to get keloids?
Yes, there's a significant genetic component to keloid susceptibility, meaning your children could inherit this tendency. While it doesn't guarantee they will develop keloids, they will likely have an increased genetic risk compared to someone without a family history. Understanding this can help with early awareness.
7. Is it normal for my keloid to be so itchy and painful?
Yes, it's quite common for keloids to cause symptoms beyond their appearance. Many people experience itching, pain, tenderness, and even a burning sensation. These symptoms are due to the excessive and abnormal growth of fibrous tissue, which can irritate nerves in the skin.
8. Can my keloids actually limit how I move my body?
Yes, absolutely. Depending on where they form and how large they grow, keloids can restrict your movement. This is particularly true if they develop over joints, as their firm and inelastic nature can prevent the skin from stretching and moving freely.
9. Could a DNA test predict my keloid risk?
Genetic research is making progress in identifying specific genetic variants linked to keloid risk. While not yet a routine diagnostic tool for everyone, future DNA tests could potentially identify your individual susceptibility. This could pave the way for personalized prevention strategies and earlier interventions.
10. Why are keloids more common in people with darker skin?
Research indicates a disproportionate prevalence of keloids in certain ethnic groups, particularly those with darker skin tones. This is largely attributed to differences in genetic architecture and allele frequencies of risk-associated variants across populations. Studies are crucial to understand these population-specific genetic underpinnings.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Dand N, et al. "GWAS meta-analysis identifies susceptibility loci for keloids and hypertrophic scarring in Europeans." J Invest Dermatol. 2025 Jun;145(6):1538-1540.e8.
[2] Ishigaki K, et al. "Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases." Nat Genet. 2020 Jul;52(7):669-676.
[3] Liu, T.Y. et al. "Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population." Sci Adv, vol. 11, 2025, eadt0539.
[4] Nakashima M, et al. "A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population." Nat Genet. 2010 Sep;42(9):768-71.